NK cell activation–related genes such as CD81, CD52, and CST7 and cytotoxicity-associated genes such as GZMA, GZMB, and GZMH were upregulated in IgG4-RD patients compared with HCs (Figure 5L). This evidence concerns the gene CD81 and immunoglobulin G4-related sclerosing disease.